Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus
Diabetes mellitus is correlated with modifications in bone microarchitectural and mechanical strength, leading to increased bone fragility. The incretin hormones, with a classical effect to increase insulin secretion following food ingestion, are now postulated to have important direct effects...
Saved in:
| 主要作者: | |
|---|---|
| 格式: | Thesis |
| 语言: | English |
| 出版: |
2015
|
| 主题: | |
| 在线阅读: | http://eprints.uthm.edu.my/1751/1/24p%20SITY%20AISHAH%20MANSUR.pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
| id |
my-uthm-ep.1751 |
|---|---|
| record_format |
uketd_dc |
| spelling |
my-uthm-ep.17512021-10-10T04:41:14Z Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus 2015-10 Mansur, Sity Aishah RC Internal medicine RC581-951 Specialties of internal medicine Diabetes mellitus is correlated with modifications in bone microarchitectural and mechanical strength, leading to increased bone fragility. The incretin hormones, with a classical effect to increase insulin secretion following food ingestion, are now postulated to have important direct effects on bone. As such, glucose-dependent insulinotropic polypeptide (GIP) has dual actions on bone cells; enhancing bone�forming activity of osteoblasts and suppressing bone resorption by osteoclasts. The sister incretin of GIP, glucagon-like peptide-1 (GLP-1), is also suspected to directly influence bone health in a beneficial manner, although mechanism are less clear at present. The physiological actions of incretins are attenuated by dipeptidyl peptidase (DPP-4) activity and it is speculated that introduction of DPP-4 inhibitor may also positively affect quality of the skeleton. As such, this thesis evaluates the potential beneficial effects of a DPP-4 resistant GIP analogue, namely [D-Ala2 ]GIP, on osteoblastic-derived, SaOS-2 cells, and also preliminary in vivo studies on the impact of genetic deficiencies of GIPRs and GLP-1Rs on bone mineral density and content. Further studies characterised the beneficial effects of incretin-based therapies on metabolic control, bone microstructure and bone mechanical integrity in animal models of pharmacologically-, genetically- and environmentally-induced diabetes. GIP and related stable analogue increased bone-forming biomarkers in SaOS-2 cells and importantly, [D-Ala2 ]GIP was shown to be more potent than native GIP. Knockout mouse studies revealed that both GIPR and GLP-1R signaling are important for optimum bone mass. All diabetic mouse models displayed reduced bone mass, altered bone micromorphology and impairment of bone mechanical strength, similar to the human situation, confirming their appropriateness. The incretin-based therapeutics, [D-Ala2 ]GIP and Liraglutide, in streptozotocin-diabetic significantly increased bone matrix properties, indicating recovery of bone strength at the tissue level. The beneficial effects of administration of [D-Ala2 ]GIP�oxyntomodulin on bone health in db/db mice were more prominent as the Oxm analogue did not only improve bone strength at tissue level, but also at whole-bone level. These modifications were independent of metabolic status. Twice-daily Exendin-4 therapy improved glycaemic control and increased work required to resist bone fracture in high-fat fed mice. It was also established that Sitagliptin had neutral effects on bone microstructure and mechanical strength in high-fat mice. In summary, these data demonstrate the negative impact of diabetes mellitus on normal skeleton development and bone quality. Moreover, this thesis highlights the growing potential of incretin-based therapies for ameliorating bone defects and improving the increased fragility fracture risk associated with diabetes 2015-10 Thesis http://eprints.uthm.edu.my/1751/ http://eprints.uthm.edu.my/1751/1/24p%20SITY%20AISHAH%20MANSUR.pdf text en public phd doctoral University of South Australia Faculty of Life and Health Sciences |
| institution |
Universiti Tun Hussein Onn Malaysia |
| collection |
UTHM Institutional Repository |
| language |
English |
| topic |
RC Internal medicine RC581-951 Specialties of internal medicine |
| spellingShingle |
RC Internal medicine RC581-951 Specialties of internal medicine Mansur, Sity Aishah Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus |
| description |
Diabetes mellitus is correlated with modifications in bone microarchitectural and
mechanical strength, leading to increased bone fragility. The incretin hormones, with
a classical effect to increase insulin secretion following food ingestion, are now
postulated to have important direct effects on bone. As such, glucose-dependent
insulinotropic polypeptide (GIP) has dual actions on bone cells; enhancing bone�forming activity of osteoblasts and suppressing bone resorption by osteoclasts. The
sister incretin of GIP, glucagon-like peptide-1 (GLP-1), is also suspected to directly
influence bone health in a beneficial manner, although mechanism are less clear at
present. The physiological actions of incretins are attenuated by dipeptidyl peptidase
(DPP-4) activity and it is speculated that introduction of DPP-4 inhibitor may also
positively affect quality of the skeleton. As such, this thesis evaluates the potential
beneficial effects of a DPP-4 resistant GIP analogue, namely [D-Ala2
]GIP, on
osteoblastic-derived, SaOS-2 cells, and also preliminary in vivo studies on the impact
of genetic deficiencies of GIPRs and GLP-1Rs on bone mineral density and content.
Further studies characterised the beneficial effects of incretin-based therapies on
metabolic control, bone microstructure and bone mechanical integrity in animal
models of pharmacologically-, genetically- and environmentally-induced diabetes.
GIP and related stable analogue increased bone-forming biomarkers in SaOS-2 cells
and importantly, [D-Ala2
]GIP was shown to be more potent than native GIP.
Knockout mouse studies revealed that both GIPR and GLP-1R signaling are
important for optimum bone mass. All diabetic mouse models displayed reduced
bone mass, altered bone micromorphology and impairment of bone mechanical
strength, similar to the human situation, confirming their appropriateness. The
incretin-based therapeutics, [D-Ala2
]GIP and Liraglutide, in streptozotocin-diabetic
significantly increased bone matrix properties, indicating recovery of bone strength
at the tissue level. The beneficial effects of administration of [D-Ala2
]GIP�oxyntomodulin on bone health in db/db mice were more prominent as the Oxm
analogue did not only improve bone strength at tissue level, but also at whole-bone
level. These modifications were independent of metabolic status. Twice-daily
Exendin-4 therapy improved glycaemic control and increased work required to resist
bone fracture in high-fat fed mice. It was also established that Sitagliptin had neutral
effects on bone microstructure and mechanical strength in high-fat mice. In summary, these data demonstrate the negative impact of diabetes mellitus on normal
skeleton development and bone quality. Moreover, this thesis highlights the growing
potential of incretin-based therapies for ameliorating bone defects and improving the
increased fragility fracture risk associated with diabetes |
| format |
Thesis |
| qualification_name |
Doctor of Philosophy (PhD.) |
| qualification_level |
Doctorate |
| author |
Mansur, Sity Aishah |
| author_facet |
Mansur, Sity Aishah |
| author_sort |
Mansur, Sity Aishah |
| title |
Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus |
| title_short |
Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus |
| title_full |
Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus |
| title_fullStr |
Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus |
| title_full_unstemmed |
Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus |
| title_sort |
extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus |
| granting_institution |
University of South Australia |
| granting_department |
Faculty of Life and Health Sciences |
| publishDate |
2015 |
| url |
http://eprints.uthm.edu.my/1751/1/24p%20SITY%20AISHAH%20MANSUR.pdf |
| _version_ |
1747830862563508224 |